MedTrace Logo

A Prospective Study in Patients Undergoing Primary Ventral Hernia Repair Using Parietex™ Composite Ventral Patch

NCT01848184 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 126

Last updated 2018-07-20

Study results available
· View outcomes & findings →

Summary

The objective of this study is to assess the recurrence rate following the use of PARIETEX™ Composite Ventral Patch in primary ventral hernia repair by open approach with intra-peritoneal positioning.

Conditions

  • Hernia

Interventions

DEVICE

PARIETEX™ Composite Ventral Patch

PARIETEX™ Composite Ventral Patch for ventral hernia repair

Sponsors & Collaborators

  • Medtronic - MITG

    lead INDUSTRY

Principal Investigators

  • Frederik Berrevoet, MD · University Hospital Ghent (Belgium)

  • Lars N Jørgensen, MD · Bispebjerg Hospital, University of Copenhagen (Denmark)

  • Carl Doerhoff, MD · Surgicare of MO (United States)

  • Steven Hopson, MD · Hernia Centers of Excellence, VA (United States)

  • Eric KULLMAN, MD · Medicinskt Centrum i Linköping (Sweden)

  • Marco G MUZI, MD · Department of Surgery, University Hospital Tor Vergata, Roma (Italy)

  • Simon NIENHUIJS, MD · Catharina Ziekenhuis, EJ EINDHOVEN (The Netherlands)

  • Filip E Muysoms, MD · Algemene Heelkunde, AZ Maria Middelares Ghent (Belgium)

  • Tim Tollens, MD · Imelda Hospital, Bonheiden (Belgium)

  • Karl Leblanc, MD · Our Lady of the Lake Regional Medical Center, LA (United States)

  • Mark Schwartz, MD · Monmouth Medical Center, NJ (United States)

  • Vic Velanovich, MD · University of South Florida (United States)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2016-07-31
Completion
2016-07-31

Countries

  • United States
  • Belgium
  • Denmark
  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01848184 on ClinicalTrials.gov